Milasen - a drug developed for a single patient.
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease | NEJM: Summary Genome sequencing is often pivotal in the diagnosis of rare diseases, but many of these conditions lack specific treatments. We describe how molecular diagnosis of a rare, fatal neurodegenerative condition led to the...
Source: nejm.org
FDA Approves Less Expensive Insulin Glargine: By Kristin J. Kelley Edited by André Sofair, MD, MPH, and William E. Chavey,
FDA Approves Less Expensive Insulin Glargine: By Kristin J. Kelley
Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS
The FDA has approved an insulin glargine injection (marketed as Basaglar) for treating type 1 (adult and pediatric patients) and … NEJM Journal Watch.
Source: jwatch.org
RSS feed